Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
InnoScience (Suzhou) Technology Holding Co Ltd Class H ( (HK:2577) ) has provided an announcement.
InnoScience (Suzhou) Technology Holding Co., Ltd. announced that its chairperson and executive director, Dr. Weiwei Luo, who is also part of the controlling shareholder group, has voluntarily committed not to sell or reduce her beneficial interests in 154,705,540 company shares, comprising both domestic unlisted shares and H shares, for a 12‑month period starting January 22, 2026. The company said this lock‑up commitment reflects Dr. Luo’s confidence in InnoScience’s long‑term growth prospects and the investment value of its GaN power chip business, and it expects the move to support the company’s stable development and signal management’s alignment with shareholders amid strong market expectations for GaN solutions across multiple energy‑related and high‑performance technology sectors.
The most recent analyst rating on (HK:2577) stock is a Buy with a HK$113.60 price target. To see the full list of analyst forecasts on InnoScience (Suzhou) Technology Holding Co Ltd Class H stock, see the HK:2577 Stock Forecast page.
More about InnoScience (Suzhou) Technology Holding Co Ltd Class H
InnoScience (Suzhou) Technology Holding Co., Ltd. is a China-incorporated semiconductor company focused on gallium nitride (GaN) power chips, targeting applications that demand high frequency, high efficiency and high power density. Its products are positioned for key growth markets including new energy vehicles, data centers, industrial energy storage, humanoid robots and consumer electronics, where the ongoing global energy transition and drive for higher energy efficiency are expanding demand for advanced power semiconductor solutions.
Average Trading Volume: 4,868,039
Technical Sentiment Signal: Hold
Current Market Cap: HK$62.96B
For a thorough assessment of 2577 stock, go to TipRanks’ Stock Analysis page.

